Clinical Trial Update: Resuscitative Endovascular Balloon Occlusion of the Aorta in Haemorrhagic Shock

View source ↗

Summary

The trial NCT05941572 evaluating resuscitative endovascular balloon occlusion of the aorta (REBOA) for hemorrhagic shock in trauma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock
• Traumatic Injury

Snippet

Sponsor: Medical University of Graz | Conditions: Non-compressible Torso Hemorrhage, Trauma Injury | Status: WITHDRAWN